
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GSDMDC1 CRISPR/Cas9 KO Plasmid (r) | sc-437380 | 20 µg | $397.00 |
Rat GSDMDC1 encodes a gasdermin domain–containing protein linked to membrane remodeling and regulated cell death programs, processes that shape innate immune signaling and tissue homeostasis. Gasdermin family members are commonly positioned downstream of inflammatory protease cascades and can influence pore formation, ion flux, and release of inflammatory mediators, thereby intersecting with pathways such as inflammasome signaling and stress-induced cytotoxicity. Although GSDMDC1 remains less extensively characterized than canonical gasdermins, its domain architecture suggests roles in epithelial integrity and injury responses. Dysregulation of gasdermin-associated pathways has been connected to inflammatory and degenerative phenotypes, making GSDMDC1 a useful target for mechanistic studies in disease-relevant rat models.
GSDMDC1 CRISPR/Cas9 KO Plasmid (r) is a pool of plasmids designed for targeted disruption of the gene in rat cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish GSDMDC1 protein expression.
This CRISPR knockout system enables efficient generation of -deficient cell models for investigation of GSDMDC1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.